BIOMAT Database Logo BIOMAT Database Logo

Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. 2004

W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Childrens Hospital Los Angeles, Department of Hematology-Oncology, Los Angeles, CA, USA.

Use of recombinant factor VIIa (rFVIIa, NovoSeven in patients with congenital FVII deficiency has been reported for the prophylactic management of surgical bleeding and for the treatment of acute bleeding episodes. Because of its short half-life, the use of rFVIIa on a regular prophylactic regimen has not been routinely adopted. In this report, we describe our successful experience with rFVIIa prophylaxis in preventing recurrent target joint bleeding in a severely FVII-deficient adolescent.

UI MeSH Term Description Entries
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005168 Factor VII Deficiency An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation. Hypoproconvertinemia,Deficiency, Factor 7,Deficiency, Factor Seven,Deficiency, Factor VII,Factor 7 Deficiency,Deficiencies, Factor 7,Deficiencies, Factor Seven,Deficiencies, Factor VII,Factor 7 Deficiencies,Factor Seven Deficiencies,Factor Seven Deficiency,Factor VII Deficiencies,Hypoproconvertinemias
D006395 Hemarthrosis Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia. Hemarthroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D015942 Factor VIIa Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation. Coagulation Factor VIIa,Factor VII, Activated,Blood Coagulation Factor VII, Activated,Factor 7A,Factor Seven A,Activated Factor VII,Factor VIIa, Coagulation

Related Publications

W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
July 2008, Haemophilia : the official journal of the World Federation of Hemophilia,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
January 2000, Seminars in thrombosis and hemostasis,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Treatment of factor VII deficiency with recombinant factor VIIa.
January 1996, Haemostasis,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
May 2002, Obstetrics and gynecology,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency.
October 2007, Thrombosis and haemostasis,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report.
April 2015, Journal of the American Dental Association (1939),
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
April 2019, European journal of obstetrics, gynecology, and reproductive biology,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
July 2011, Haemophilia : the official journal of the World Federation of Hemophilia,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
October 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
W Y Tcheng, and J Donkin, and S Konzal, and W-Y Wong
Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency. A case report.
February 2007, The Journal of bone and joint surgery. American volume,
Copied contents to your clipboard!